tag:blogger.com,1999:blog-62764722968066179232024-03-05T01:44:35.430-08:00Medtech VenturesRonhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comBlogger18125tag:blogger.com,1999:blog-6276472296806617923.post-41335244070622698942020-09-26T08:57:00.000-07:002013-10-10T02:08:50.835-07:00From Concept to Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJBOmIgkfbzMBjDbXEp5yp-gr_nc4tht107E2Tic157wr2ciP2PqPRjFXXg9ZszZ0uXJliFKuHLUn2ap_f7By_O925jl_NerO7oc_W2ocVeRDW6bzEqRAv6nhTSoNxj1D3fnaes_cIrUo/s1600/Concept.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="213" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJBOmIgkfbzMBjDbXEp5yp-gr_nc4tht107E2Tic157wr2ciP2PqPRjFXXg9ZszZ0uXJliFKuHLUn2ap_f7By_O925jl_NerO7oc_W2ocVeRDW6bzEqRAv6nhTSoNxj1D3fnaes_cIrUo/s320/Concept.jpg" width="320" /></a><b>Medtech Ventures</b> is a forward looking think tank and virtual startup accelerator specialized in the medical technology industry. <br />
<br />
We offer our clients a broad portfolio of services revolving around the concept of "<a href="http://www.medtechventures.com/2013/08/Virtual-Incubator.html">Virtual Incubation</a>".<br />
<br />
We help with idea evaluation, opportunity sizing, technology assessment, market analysis as well as perception management and venture capital sourcing and finance.<br />
<br />
We also publish brief market insight & niche opportunity reports targeted at senior executives in the medical technology field.<br />
<br />
Interested? Drop us a line and one of our partners will get in touch with you ASAP.
</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-83296693354707870412019-09-26T03:03:00.000-07:002013-09-19T08:30:37.174-07:00Good Advice, Pass It On<div dir="ltr" style="text-align: left;" trbidi="on">
According to <b>Oscar Wilde</b>:<br />
"<i>The only thing to do with good advice is to pass it on.</i><br />
<div class="separator" style="clear: both; text-align: center;">
<i><a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgb641_OKSXUhqJ7cLUyXDjn0oiyxTCNE6rQobi-oiBeeBNt3IT6-J2VGAKtM8jn0SOvwZsYoT2SQi3vxpuC2v1axxxUCEzL17ht5XIxKwKk91K9cnCXXYO_A-eVnk_StWYrwztW-zpyz8/s1600/Advice.gif" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgb641_OKSXUhqJ7cLUyXDjn0oiyxTCNE6rQobi-oiBeeBNt3IT6-J2VGAKtM8jn0SOvwZsYoT2SQi3vxpuC2v1axxxUCEzL17ht5XIxKwKk91K9cnCXXYO_A-eVnk_StWYrwztW-zpyz8/s1600/Advice.gif" /></a></i></div>
<i>It is never of any use to oneself.</i>"<br />
<br />
At <b>Medtech Ventures</b> we pass on good advice in the form of short reviews of recommended articles, books or new technologies. Drop by often, you might be<br />
pleasantly surprised.<br />
<br />
For <b>One-on-One Coaching</b>,<br />
feel free to <a href="http://www.medtechventures.com/p/contact.html">drop us a line...</a>,</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-52454949050779425182019-09-18T07:51:00.000-07:002013-09-19T09:06:34.410-07:00Less Is More<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhApS3KNa8MB451hLRXBJuT5YmmicOdH3cnZqAbfefKDzHMeFxpiQm2uvhipk3-EMDcrnC1tmeoTF1kD6_21-0LcgMgK0_iXY4Qf460dqcEkXO0-9DGaEPO8SgedgefsUA_AgPthIu95Tw/s1600/less-is-more.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhApS3KNa8MB451hLRXBJuT5YmmicOdH3cnZqAbfefKDzHMeFxpiQm2uvhipk3-EMDcrnC1tmeoTF1kD6_21-0LcgMgK0_iXY4Qf460dqcEkXO0-9DGaEPO8SgedgefsUA_AgPthIu95Tw/s1600/less-is-more.jpg" /></a>If its your first product then try to go for less. <br />
<br />
Conventional wisdom says that you should beat the competitors by offering more; more features, more options and more preferences.<br />
<br />
This sort of one-upping Cold War mentality is an expensive way of building products that would overwhelm and confuse the end user.<br />
<br />
Barebone less, less features, less options, less people and corporate structure, less meetings and, definitely, less promises.<br />
<br />
Then, when you finally get it, iterate . . .,</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-59686688275421682742019-09-01T04:05:00.000-07:002020-01-19T01:04:20.695-08:00Aortic Intervention Market - Horizon 2025<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: left;">
<a href="https://secure.2checkout.com/checkout/buy?merchant=1912926&tpl=default&prod=8&qty=1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="Aortic Intervention Market" border="0" data-original-height="24" data-original-width="103" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj2TQS-QSTrZDQriAiAqD_ydrHB-sGbPabe-oycXG4KVFdzwBSNgx4HKkj-5YKTkUXCG0Kv40ANfgkbL844SYn7aACHhy_ppmlgN9B-hqeOX87NUB4fYtd4l0CMmKGRWalxbhSBbVga-Lw/s1600/Order-Report.png" /></a> Global <b>Aortic Intervention Market</b>, which currently stands at $2.3 billion, has matured. The market, which is consolidating, has been growing at an average annual growth rate of 6% over the past decade.</div>
<br />
<a name='more'></a><b>Medtronic</b>, <b>Cook</b>, <b>Gore</b>, <b>Terumo</b> and <b>Endologix</b> are currently the top five leading companies operating in the space, and the size of their market share reflects the order in which they have been mentioned.<br />
<br />
Advances in aortic imaging coupled with development in endovascular technology have transformed the aortic intervention landscape with penetration levels of endovascular aneurysm repair reaching over 75% of total repair procedures in technologically advanced countries.<br />
<br />
Endovascular aortic endografts have evolved rapidly over the last three decades. Current generation of ultra-low profile stent grafts have become commodities. Still, several unresolved issues remain, including high long-term rates of complications and reinterventions, as well as uncertainties about device performance and durability beyond 10 years.<br />
<br />
Aortic branch management strategies represent the next frontier in endovascular aortic aneurysm repair with the promise to expand applicability into the thoracoabdominal space and the aortic arch, an estimated $900 million in new market potential. The only two current innovations dealing with the visceral aorta and the aortic arch are fenestrated and flow diverting endografts.<br />
<br />
<b>Medtech Ventures</b>’ analysts, who have been tracking and documenting the Aortic Intervention space since its inception, are conducting a <b>Scenario Planning</b> exercise that involves digital conversation with top leaders and visionaries in a space.<br />
<br />
Results of this exercise will be summarized in an off-the-shelf supply-side industry report that will assess the current strategic landscape of the Aortic Intervention market and will offer a consensus-based preferred future. It will also make available an event impacted linear forecast to 2025.<br />
<br />
The report will be released to all per-ordering clients on September 18th 2019, one day before 19.09.19, Aortic Disease Awareness Day.<br />
<br />
<div style="text-align: center;">
<u><span style="font-size: small;"><a href="https://secure.2checkout.com/checkout/buy?merchant=1912926&tpl=default&prod=8&qty=1"><b>Order Report</b></a></span> </u> </div>
<div style="text-align: center;">
<br /></div>
<div style="text-align: center;">
<b>Published: September 18th, 2019 - 42 Pages - PDF by eMail </b></div>
<br />
Senior executives and strategists who would order the report before September 13th 2019, will get a chance to contribute and feedback on final report before it is released. Everyone can join the conversation by sending us their insights, if they are qualified Aortic Intervention visionaries they will be invited for one to one interviews.<br />
<br />
<br />
<br />
<br /></div>
aihttp://www.blogger.com/profile/00230441185427963788noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-82787423331553410682018-09-26T08:25:00.000-07:002013-09-19T09:04:41.631-07:00Virtual Startup Incubator<div dir="ltr" style="text-align: left;" trbidi="on">
Virtual startup incubation meets the needs of most modern<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3-sAifD-BxYhJg_cxkIfOk7W6LWV6iV9fQdkX4P7eiumXeGS5AzHkmSo0xrbgzsVtEOhYSSEaI5nP1A4q0pgbmVKbtt7uDSLi4K2Xgpa4S8lzZRRR-_psF9nRg8W70C9ogHkjJF8Fd6k/s1600/Virtuali.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg3-sAifD-BxYhJg_cxkIfOk7W6LWV6iV9fQdkX4P7eiumXeGS5AzHkmSo0xrbgzsVtEOhYSSEaI5nP1A4q0pgbmVKbtt7uDSLi4K2Xgpa4S8lzZRRR-_psF9nRg8W70C9ogHkjJF8Fd6k/s1600/Virtuali.jpg" /></a></div>
entrepreneurs who need advice, support, and access to startup
acceleration services that incubators provide.<br />
<br />
Traditional business incubators require a startup business to establish a physical presence at their location. The idea is that the new startup can establish itself in an environment that offers support through business advice and shared common services.<br />
<br />
Virtual business incubators offer a more flexible solution that is better suited to modern day startups. It allows high-tech entrepreneurs to take advantage of the professional business, support services and the advice, without the need to relocate to, or occupy, a physical site. <br />
<br />
Virtual incubation allows entrepreneurs find
the best services that are available to their field and source them globally
aided by state-of-the-art ICT infrastructure, scientific and technological social networks and a thriving tribal conferencing culture.<br />
<br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-72412620160818381602018-01-27T11:01:00.000-08:002013-10-13T07:17:58.090-07:00Time Is The Ultimate Currency<div dir="ltr" style="text-align: left;" trbidi="on">
<div style="text-align: left;">
<b><a href="http://www.medtechventures.com/search/label/Pharma"></a></b></div>
<div style="text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZkbeep8y7B02dASxbCXqXmZ2sLkafGIjHFKjkZwVmC4tDGkxw1V-9CXhskofwxwhQLHlHpYLPWyXgvd2y6XfkttkaYnoIy4owBOMPLhE1C5EbCM5PC4b-iP7EUdKeZ3oaQFOBj0pq9LA/s1600/Report.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="170" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiZkbeep8y7B02dASxbCXqXmZ2sLkafGIjHFKjkZwVmC4tDGkxw1V-9CXhskofwxwhQLHlHpYLPWyXgvd2y6XfkttkaYnoIy4owBOMPLhE1C5EbCM5PC4b-iP7EUdKeZ3oaQFOBj0pq9LA/s320/Report.jpg" width="320" /></a><b></b></div>
<b>Medtech Ventures</b>' Strategic Consulting Reports are short insightful quality documents targeted at senior executives in the medical technology and venture capital industries.<br />
<br />
We know you are busy, we know you have access to all available information and that your time comes at a premium.<br />
<br />
We offer helicopter view insights and <a href="http://www.medtechventures.com/p/contact.html">always available</a> to discuss your specific information needs.</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-57837777259635186992017-09-26T02:50:00.000-07:002013-09-19T23:58:07.595-07:00Timely News, Analysis & Insights<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEic-nP_uy8HnIEJhieWVZTWUSDUQHg8gAU5dCTS8bhbEn9nHe31wWoHWD6Ht4g6Uxmjz14P7feMUfzlzMceRgxStVdrDmIFW8M1VMBHjKUebXzvNeEeKkKLi49OTifFaxlCHy6HYIKV30I/s1600/Newsletter.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" height="170" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEic-nP_uy8HnIEJhieWVZTWUSDUQHg8gAU5dCTS8bhbEn9nHe31wWoHWD6Ht4g6Uxmjz14P7feMUfzlzMceRgxStVdrDmIFW8M1VMBHjKUebXzvNeEeKkKLi49OTifFaxlCHy6HYIKV30I/s320/Newsletter.jpg" width="320" /></a><b>Medtech Ventures</b> publishes an expanding portfolio of newsletters covering niche segments in the biotech, medical device, and pharma industries. <br />
<br />
All our newslleters are available on free trial basis. Simply chose the newsletter covering your specific area of interest, fill in the application form and you are on your way to receiving the most recent analysis and insights on the medical technology niche of your choosing.<br />
<br />
Published specifically for senior executives and investment professionals, <b>Medtech Ventures</b>' newsletters brings together the perspectives of clinicians, industry insiders, and respected industry analysts to provide rare insights into the true drivers and opportunities of novel medical technologies. <br />
<br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-49541067059063390442016-09-19T02:33:00.000-07:002013-09-20T03:53:00.320-07:00Endovascular Market Trends<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=100" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgAcqF905zpMqHXrqxt0nXC68Lt2Q8WDsFDaxAIBSJLD4DBuq84_OaqFWc96qw6mt7ok_1ykUY79a-Gk36EfdLHX_vqlohN2bVrideksj3QiTteF4y9kl4BWXQlxOfcZAGczuyGguKKDuE/s1600/Order-Report.png" /></a>Buoyed by favorable patient demographics, technology advancement, and cross-specialty physician interest, the endovascular device market has
been experiencing exceptional double digit growth rates of late.<br />
<br />
Endovascular Market Trends is a quarterly newsletter focused on the global endovascular space, in its broadest sense. It covers the cardiac, coronary, neuro and peripheral segments of the market with news, analysis and foresight.<br />
<br />
An indispensable resource for top executives, the newsletter assists informed and effective decision-making. It tracks both established multinationals, innovative startups and emerging technologies and delivers the insight they need to construct winning strategies and anticipate future market developments. <br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-80919448900069250242016-05-20T22:39:00.000-07:002016-05-22T08:30:57.451-07:00Emerging Liquid Biopsy Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=9" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=9" border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgHOhpvzuxuQwjaQPjsaoRPZauBQk2bBtPixZE0i2g7j28lCl4DX4JlJgOuTBAMqRch6UJFzrzYcxAhDLhZ-qoVTeQnRMyvyuLk_F9PSbYn-hUz1AT84SUI3258IaStrFHY4bL57A_qMcU/s1600/Order-Report.png" /></a>Recent advances in genotyping and sequencing technologies are turning liquid biopsies into a clinically viable alternative to tissue biopsies, the current gold standard for making treatment decisions.<br />
<br />
As research validates the ability of liquid biopsies to screen asymptomatic patients, detect cancer, measure tumor burden, predict recurrence, monitor disease progression and evaluate response to treatment, the quest for developing clinically actionable liquid biopsy tests has just started.<br />
<br />
<a name='more'></a>The rapid drop in cost of analyzing genetic information combined with the increase in use of targeted cancer therapeutics are opening windows of opportunities for start-ups with the right technologies. <br />
<br />
Many innovative start-ups are exploring liquid biopsy's potential for providing oncologists with a faster, cheaper and less invasive way to assess colorectal, lung, prostate, breast and ovarian cancer patients' clinical status and response to treatment. <br />
<br />
Combining liquid biopsies with personalized therapies has the potential to revolutionize cancer care and the market opportunity is attracting attention from a wide range of companies into this rapidly evolving field and accelerating the pace of acquisitions in the space.<br />
<br />
Targeted at senior executives in the medical diagnostics industry, Medtech Ventures’ “Emerging Liquid Biopsy Market” report explores emerging business models, revenue potential and successful growth strategies in this rapidly evolving field.<br />
<br />
The report sizes the current liquid biopsy market, profiles key players and offers a rational overview of this emerging sector with a sober forecast to 2020.<br />
<br />
<b> Published: May 2016 - #37 Pages - PDF by eMail</b><br />
<br />
<b>Table of Contents</b><br />
<br />
<b>1. Liquid Biopsy</b><br />
<br />
1.1 Circulating Tumor Cells<br />
1.2 Cell Free DNA<br />
1.3 Exosomes<br />
<br />
<b>2. The Medical Diagnostics Industry</b><br />
<br />
2.1 Medical Diagnostics Market Size & Growth Rate<br />
2.2 Medical Diagnostics Industry Segmentation<br />
2.3 Leading Players in the Medical Diagnostics Industry<br />
<br />
<b>3. Molecular Diagnostics Market</b><br />
<br />
3.1 Molecular Diagnostics Market Size & Growth Rate<br />
3.2 Molecular Diagnostics Market Segmentation<br />
3.3 Leading Players in the Molecular Diagnostics Market<br />
<br />
<b>4. Liquid Biopsy Market</b><br />
<br />
4.1 Liquid Biopsy Market Revenue & Growth Rate<br />
4.2 Top Five Liquid Biopsy Companies <br />
4.3 Leading Companies Market Shares<br />
4.4 Other Companies to Watch Within the Liquid Biopsy Space <br />
4.5 Business Models in the Liquid Biopsy Space<br />
4.6 Liquid Biopsy Applications <br />
4.7 Mergers, Acquisitions & Licensing Deals<br />
<br />
<b>5. Future Outlook</b><br />
<br />
5.1 Technology Trajectory<br />
5.2 Potential Market<br />
5.3 Market Forecast<br />
<br />
<b>6. Companies In The Space</b><br />
<br />
1. AdnaGen<br />
2. Agena Bioscience<br />
3. Angle PLC<br />
4. ApoCell<br />
5. Biocept<br />
6. BioFluidica<br />
7. Bio-Rad<br />
8. Boreal Genomics<br />
9. Caris Life Sciences<br />
10. Chronix Biomedical<br />
11. Clearbridge Biomedics<br />
12. Cynvenio Biosystems<br />
13. CytoLumina Technologies<br />
14. CytoTrack <br />
15. Diagnologix<br />
16. Epic Sciences<br />
17. Exact Sciences<br />
18. Exosome Diagnostics<br />
19. Exosome Sciences<br />
20. Fluxion Biosciences<br />
21. Foundation Medicine<br />
22. Genomic Health<br />
23. Grail<br />
24. Guardant Health <br />
25. iCellate<br />
26. Illumina<br />
27. Inivata<br />
28. Invitae<br />
29. Janssen Diagnostics<br />
30. MDxHealth<br />
31. NeoGenomics<br />
32. Pathway Genomics<br />
33. PrecisionMed<br />
34. Qiagen<br />
35. RainDance Technologies<br />
36. Roche <br />
37. Sequenom<br />
38. Siemens<br />
39. Theranos<br />
40. ThermoFisher <br />
41. TransGenomic<br />
42. Trovagene <br />
<br />
<b>Tables & Figures</b><br />
<br />
1. Clinical Applications of Liquid Biopsy<br />
2. Role of Medical Diagnostics in Modern Health Care<br />
3. Global Medical Diagnostics Market Revenue (2010 - 2015)<br />
4. Medical Diagnostics Market Segmentation by Test Discipline (2015)<br />
5. Medical Diagnostis Industry – Leading Companies Market Share (2015)<br />
6. Global Molecular Diagnostics Market Revenue (2010 – 2015)<br />
7. Molecular Diagnostics Market Segmentation (2015)<br />
8. Molecular Diagnostics Market – Leading Companies Market Share (2015)<br />
9. Liquid Biopsy Market Market Revenue (2010 – 2015)<br />
10. Top Five Liquid Biopsy Companies (2015)<br />
11. Exact Sciences: Completed Cologuard Tests (2015)<br />
12. Liquid Biopsy Market - Leading Companies Market Shares (2015)<br />
13. Liquid Biopsy Market - Business Models Segmentation (2015) <br />
14. Liquid Biopsy Market - Application Segmentation (2015)<br />
15. Top Acquisitions in the Liquid Biopsy Space (2015)<br />
16. Comparison of Analysis Capability of CTCs, cfDNA and Exosomes<br />
17. Common Cancer Types - Developed World Estimated New Cases (2015)<br />
18. Liquid Biopsy Market Forecast (2016 – 2020)</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-71956953688741220612016-02-23T04:23:00.000-08:002016-02-23T02:00:00.207-08:00Aortic Endografts Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=1" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEMnMkmi0ogURyrhOWXVNHaGwyaub_vBMP9_ggTHt_82nERASe2JSpF_AJ1GuDDjSDng8K12SlAWH6wxa992ZqOkAJveGawVuVEk5paGRZBcWgbPbXVPF8CvfktlQeCMDIHyMpKqO2NUI/s1600/Order-Report.png" /></a>The aortic intervention market has consolidated. During 2015, Medtronic acquired Aptus Endosystems for $110 million, Lombard Medical acquired Altura Medical for $23 million and Endologix merged with TriVascular in a $211 million deal.<br />
<br />
The only innovative company left standing independent in the space is Cardiatis, which is expected to be acquired during 2016 given its disruptive aortic flow diversion technology, its extensive patent portfolio, and the recent Veith symposium presentations highlighting the utility of its technology in repairing difficult to treat thoraco-abdominal aneurysms .<br />
<br />
<a name='more'></a>According to Medtech Ventures’ analysts, the global aortic endografts market was estimated at $1.8 billion in 2015, a growth of 6% over its level in 2014. At $1.4 billion in revenue, the infra-renal segment of the market has matured but is expected to continue growing in the low-single digit range during the rest of the decade.<br />
<br />
Aortic branch management strategies represent the next frontier in endovascular aortic aneurysm repair with the promise to expand applicability into the thoracoabdominal space and the aortic arch, an estimated $900 million in new market potential.<br />
<br />
Fenestrated and branched endografts are being used in many centers and have increased the proportion of aortic aneurysms treated endovascularly. During the rest of the decade these devices will become perfected, simpler to use and stockable in off-the-shelf configurations.<br />
<br />
The acceptance of the off-the-shelf aortic flow diversion technology that can bridge and preserve circulation in the celiac, superior mesenteric and the renals, is a game changer and promises to breathe new growth into the overall market.<br />
<br />
Medtech Ventures’ Aortic Endografts Market report offers senior executive in the medical technology industry a comprehensive overview of the market with a consensus forecast to 2020 supported by three event impacted scenarios.<br />
<br />
The report, which has been tracking this highly guarded space since 2008, is the definitive guide to the current industry landscape. Companies profiled include: Bolton Medical, Braile Biomedica, Cardiatis, Cook Medical, Cordis, Endologix, Endospan, Gore Medical, Jotec, Lifetech Scientific, Lombard Medical, Medtronic, Microport Medical, Nano Endoluminal, and Terumo.<br />
<br />
<div style="text-align: center;">
<b>Published: February 2016 - #30 Pages - PDF by eMail</b></div>
<br />
<br />
<b>Table of Contents</b><br />
<br />
<b>1. Executive Summary</b><br />
<br />
<b>2. Aortic Aneurysms</b><br />
<br />
2.1 Open Surgical Repair of Aortic Aneurysms<br />
2.2 Endovascular Repair of Aortic Aneurysms<br />
<br />
<b>3. Aortic Endografts Market</b><br />
<br />
3.1 Leading Companies & Their Devices<br />
3.2 Recent Mergers & Acquisitions in the Space <br />
3.3 Leading Companies Market Shares<br />
3.4 Geographic Segmentation<br />
<br />
<b>4. Market Segmentation</b><br />
<br />
4.1 Infra-Renal Aortic Endografts Market<br />
4.2 Thoracic Aortic Endografts Market<br />
4.3 Fenestrated & Branched Aortic Endografts<br />
4.4 Aneurysm Sealing Endografts<br />
4.5 Aortic Flow Diverting Endografts<br />
<br />
<b>5. Market Forecast</b><br />
<br />
5.1 Endovascular Opportunity In Thoraco-Abdominal Aneurysm Repair<br />
5.2 Endovascular Opportunity In Aortic Dissection Repair<br />
5.3 Endovascular Opportunity In Ascending Aortic Arch Aneurysms <br />
5.4 Future Scenarios<br />
<br />
<b>6. Companies In The Space</b><br />
<br />
6.1 Bolton Medical<br />
6.2 Braile Biomedica<br />
6.3 Cardiatis<br />
6.4 Cook Medical<br />
6.5 Cordis<br />
6.6 Endologix<br />
6.7 Endospan <br />
6.8 Gore Medical<br />
6.9 Jotec<br />
6.10 Lifetech Scientific<br />
6.11 Lombard Medical<br />
6.12 Medtronic<br />
6.13 Microport Medical<br />
6.14 Nano Endoluminal<br />
6.15 Terumo<br />
<br />
<br />
<b>List of Tables & Figures</b><br />
<br />
1. Global Aortic Endografts Market (2010 - 2015)<br />
2. Top Five Aortic Endograft Companies<br />
3. Recent Mergers & Acquisitions in the Space<br />
4. Leading Companies Market Shares (2015)<br />
5. Geographic Segmentation of the Aortic Endografts Market (2015)<br />
6. Global Infra-Renal Aortic Endografts Market (2010 - 2015)<br />
7. Current Generation Infra-Renal Aortic Endografts<br />
8. Global Thoracic Aortic Endografts Market (2010 - 2015)<br />
9. Current Generation of Thoracic Endografts<br />
10. Aortic Endografts Market Forecast (2016 - 2020)<br />
11. Aortic Endografts Market – Future Scenarios (2016 - 2020)<br />
12. Cook Medical Aortic Endografts Portfolio<br />
13. Endologix Aortic Endografts Portfolio<br />
14. Medtronic Aortic Endografts Portfolio</div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-23770586766434483402014-10-01T06:46:00.000-07:002015-02-05T00:14:35.046-08:00Endovascular Cerebral Aneurysm Repair Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=10" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiV9EKTIXVWH1aLqw-5H__D2r_ZL4pwiCM872Gsg90Dy5AkkdjhEFZlZtKdWqgsX7Ueo2I2LdX645gXRWsiyfVrvMklanZLXcmOPrGdYpCCPzj5Zg2g7Yi73m9-cu_TssQY3zfH0y4Bo-Q/s1600/Order-Report.png" /></a>
The global market for endovascular cerebral aneurysm repair (ECAR) devices has surpassed the $1 billion mark and currently stands at US$1.1 billion. The market, which has experienced explosive growth over the previous decade, has matured at the current level of technology.<br />
<br />
<a name='more'></a>In its purest form, the endovascular cerebral aneurysm repair market consists of three broad categories of minimally invasive devices; embolic coils, intracranial stents and access devices.<br />
<br />
When used alone, or in combination, they allow the intervening physician to use the patient's arteries as highways to deliver intended therapies, in the form of coils or stents, to the aneurysm location within the patient's brain. The delivery procedure is performed under real-time visual guidance from high-powered imaging machines in a neurointerventional suite.<br />
<br />
The endovascular cerebral aneurysm repair market experienced a phenomenal growth phase that saw revenue rise over ten folds in just over a decade, from less than $100 million in 2000 to its current level of $1.1 billion.<br />
<br />
Current market leaders are seeking cost reductions and profit maximization through consolidation and moving production to lower cost jurisdictions. However, new research in endothelial biology is ushering in a new breed of biotech startups in search for disease modifying molecular targets, which could, theoretically, disrupt the market before the end of this decade.<br />
<br />
<b>Medtech Ventures</b>' Endovascular Cerebral Aneurysm Repair Market Report is an exclusive update to the recently changed global landscape of this market. It provides a brief, but thorough, analysis of the market with profiles of leading participant and a solid forecast to 2020.<br />
<br />
<div style="text-align: center;">
<b>Published June 2014 - 29 Pages - PDF by eMail </b></div>
<br />
<b>Contents:</b><br />
<br />
1. Global Endovascular Cerebral Aneurysm Repair (ECAR) Market<br />
<br />
2. Leading Companies & Their Devices<br />
<br />
2.1 Stryker: Neurovascular Business Unit<br />
2.2 Covidien: Neurovascular Business Unit<br />
2.3 Johnson & Johnson - Codman Neurovascular <br />
2.4 Terumo - MicroVention Subsidiary<br />
2.5 Balt Extrusion<br />
<br />
3. Leading Companies Market Shares<br />
<br />
4. Geographic Segmentation<br />
<br />
4.1 US Endovascular Cerebral Aneurysm Repair Market <br />
4.2 European Endovascular Cerebral Aneurysm Repair Market<br />
4.3 Japanese Endovascular Cerebral Aneurysm Repair Market <br />
4.4 Chinese Endovascular Cerebral Aneurysm Repair Market<br />
4.5 Latin American Endovascular Cerebral Aneurysm Repair Market<br />
<br />
5. Other Companies In The Space<br />
<br />
6. Endovascular Cerebral Aneurysm Repair Technology Update<br />
<br />
7. Mergers, Acquisitions and Valuations in the Neurovascular Space<br />
<br />
8. Endovascular Cerebral Aneurysm Repair Market Forecast<br />
<br />
<b>Graphs & Tables </b><br />
<br />
1. Global Sales of Endovascular Cerebral Aneurysm Repair Devices (2008 - 2013)<br />
2. Cerebral Aneurysm Repair Market Revenue & Growth Rates (2008 - 2013)<br />
3. Leading Companies Main Offerings (2014)<br />
4. Stryker: Neurovascular Intervention Business (2013)<br />
5. Covidien: Neurovascular Intervention Business (2013)<br />
6. Johnson & Johnson: Codman Neurovascular Intervention Business (2013)<br />
7. Terumo: MicroVention Neurovascular Intervention Business (2013)<br />
8. Balt Neurovascular Intervention Business - Device Category Segmentation (2013)<br />
9. Leading Companies Market Shares (2013)<br />
10. Geographic Segmentation (2013)<br />
11. US Endovascular Cerebral Aneurysm Repair Market (2008 - 2013)<br />
12. Europe Endovascular Cerebral Aneurysm Repair Market (2008 - 2013)<br />
13. Japan Endovascular Cerebral Aneurysm Repair Market (2008 - 2013)<br />
14. China Endovascular Cerebral Aneurysm Repair Market (2013)<br />
15. Latin America Endovascular Cerebral Aneurysm Repair Market (2013)<br />
16. Other Companies In The Space <br />
17. Valuation Multiples in the Neurovascular Space<br />
18. Endovascular Cerebral Aneurysm Repair Market Forecast (2014 - 2020)<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-32115560912083933982014-06-10T07:29:00.000-07:002014-06-01T20:16:57.203-07:00Endovascular Aneurysm Repair Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=5" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=5" border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgMv2QY6T1Dm1e5gUsHnyAdP1n2DcCEzFD-o-yMhcCYx8jVewtpE2DuymDU6wanSVmos7wN-eMV9w7FE5RAqmxToiA48zZRixB5gA10FpYvvYy0nIDzcbsawj9L2Y0hUbT4nvBamxCLq-g/s1600/Order-Report.png" /></a>Industry boundaries are imaginary lines arbitrarily drawn along technologies, markets and target customer lines to aid analysis needs of planners and strategists operating within the defined segment.
<br />
<br />
<a name='more'></a>The market for endovascular aneurysm repair, regardless of location, lends itself readily to such a definition of a well defined market that has already exceeded $3 billion in annual revenue and is well on its way to achieve $5 billion in annual sales before the end of 2020. <br />
<br />
Capitalizing on recent research on the endothelial homeostasis hypothesis of aneurysm initiation, progression and rupture, <b>Medtech Ventures</b>’ analysts have developed a unique new way of looking at the endovascular aneurysm repair market that allows strategists to devise new ways of expanding their product lines, fortify their market positions, acquire relevant innovative start-ups and expand the total size of the pie for all involved.<br />
<br />
With heightened acquisition activity, the endovascular aneurysm repair market is already consolidating at a breakneck speed, however with the recent successful IPOs of TriVascular (NASDAQ:TRIV) and Lombard Medical (NASDAQ:EVAR) the market is gearing for a new dynamic phase.<br />
<br />
The Endovascular Aneurysm Repair report, which is targeted at senior executives, explores the landscape of an expanded space that encompass aortic, cerebral and peripheral aneurysms.<br />
<br />
The report maps the competitive landscape in the newly envisioned market space, profiles leading companies strategic positions as well as innovative start-up offerings. It also volunteers suggestions towards high value chain consolidation scenarios beneficial to all.<br />
<br />
Recent acquisition deals and IPO activities are profiled and valuation metrics are provided for the brave heart among stakeholders who wish to continue with the acquisition spree to further consolidate this potentially lucrative high stakes market and to set the research and development agenda for a new generation of products that could bridge both the medical device and the biotech realms.<br />
<br />
Companies profiled in the report include: Medtronic, Gore Medical, Cook Medical, Stryker, Covidien, Terumo, Johnson & Johnson, Endologix and TriVascular.<br />
<br />
Other companies mentioned include: Altura, Aptus Endosystems, Balt, Bolton Medical, Braile Biomedica, Cardiatis, Exelixis, Jotec, Lifetech Scientific, Lombard Medical, Merlin MD, Microport Medical, Nano Endoluminal, NeuroVasx, Phenox GmbH, Penumbra, Sequent Medical and Valor.<br />
<br />
<div style="text-align: center;">
<b>Published May 2014 - 60 Pages - PDF by eMail</b> </div>
<br />
<b>Contents:</b><br />
<br />
<br />
1. Global Endovascular Aneurysm Repair Market Analysis<br />
<br />
2. Anatomical Segmentation <br />
<br />
2.1 Global Aortic Endovascular Aneurysm Repair Market<br />
2.2 Global Cerebral Endovascular Aneurysm Repair Market<br />
2.3 Global Peripheral Endovascular Aneurysm Repair Market<br />
<br />
3. Leading Companies Strategic Positions & Device Offerings <br />
<br />
3.1 Medtronic<br />
3.2 Gore<br />
3.3 Cook<br />
3.4 Stryker<br />
3.5 Covidien<br />
3.6 Terumo<br />
3.7 Johnson & Johnson<br />
3.8 Endologix<br />
3.9 TriVascular<br />
<br />
4. Leading Companies Market Shares<br />
<br />
5. Recent Acquisitions & Future Acquisition Opportunities <br />
<br />
5.1 Recent Acquisitions in the Space & Their Valuation Metrics<br />
5.2 Recent IPOs in the Space & Their Current Valuations<br />
5.3 Innovative Startups & Their Technologies<br />
5.4 Potentially Synergistic Future Acquisition Deals<br />
<br />
6. Geographic Segmentation<br />
<br />
6.1 US Endovascular Aneurysm Repair Market<br />
6.2 European Endovascular Aneurysm Repair Market<br />
6.3 Japanese Endovascular Aneurysm Repair Market<br />
6.4 Chinese Endovascular Aneurysm Repair Market<br />
6.5 Latin America Endovascular Aneurysm Repair Market<br />
<br />
7. Technology Update<br />
<br />
7.1 Endothelial Homeostasis Hypothesis<br />
7.2 Hemodynamic Modulation Technology <br />
7.3 Novel Biological Therapeutic Targets<br />
7.4 Current Status of Endovascular Aortic Aneurysm Repair<br />
7.5 Current Status of Endovascular Cerebral Aneurysm Repair<br />
7.6 Current Status of Endovascular Peripheral Aneurysm Repair<br />
<br />
8. Endovascular Aneurysm Repair Market Forecast<br />
<br />
<b>Tables & Figures</b><br />
<br />
1. Global Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
2. Global Endovascular Aneurysm Repair Revenue & Growth Rates (2008 - 2013)<br />
3. Strategic Gaps In the Global Endovascular Aneurysm Repair Market (2014)<br />
4. Anatomical Segmentation of The Endovascular Aneurysm Repair Market (2013)<br />
5. Endovascular Aneurysm Repair - Leading Companies Market Shares (2013)<br />
6. Endovascular Aortic Aneurysm Repair Sales Trend (2008 - 2013)<br />
7. Endovascular Aortic Aneurysm Repair Revenue & Growth Rates (2008 - 2013)<br />
8. Aortic Aneurysm Repair - Leading Companies Market Shares (2013)<br />
9. Endovascular Cerebral Aneurysm Repair Sales Trend (2008 - 2013)<br />
10. Endovascular Cerebral Aneurysm Repair Revenue & Growth Rates (2008 - 2013)<br />
11. Cerebral Aneurysm Repair - Leading Companies Market Shares (2013)<br />
12. Endovascular Peripheral Aneurysm Repair Sales (2013)<br />
13. US Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
14. US Endovascular Aneurysm Repair Market Segmentation (2013)<br />
15. Europe Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
16. Europe Endovascular Aneurysm Repair Market Segmentation (2013)<br />
17. Japan Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
18. Japan Endovascular Aneurysm Repair Market Segmentation (2013)<br />
19. China Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
20. China Endovascular Aneurysm Repair Market Segmentation (2013)<br />
21. Latin America Endovascular Aneurysm Repair Sales Trend (2008 - 2013)<br />
22. Latin America Endovascular Aneurysm Repair Market Segmentation (2013)<br />
23. Endothelial Homeostasis Hypothesis <br />
24. Valuation Metrics In The Endovascular Aneurysm Repair Space<br />
25. Global Endovascular Aneurysm Repair Market Forecast (2014- 2020)<br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-62110785628822649742013-10-01T07:19:00.000-07:002013-10-13T07:18:13.152-07:00Transcatheter Aortic Valves Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=4" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhyAkOTg9EVnT8XJUO0zFgn-IzCJbzwI8A9iHzSCtOHpkxypjyJH_SnGwq9Nm1KAl0k26poUOrqxN_-a_uI8-W6m3yCVznV0CyBEaa8neWnxyM6WMrETmXmf9xDAo1E4MFOnJQAF3_8OO0/s1600/_gotoStore-.png" /></a>The global transcatheter aortic heart valves market, which has surpassed the $1 billion mark in 2013, still shows strong signs of continued growth. The recent opening of the Japanese market couple with continued growth in the US are key drivers of growth.<br />
<br />
<a name='more'></a>Iterative device improvements couple with exceptional clinical outcomes are keeping interventional cardiologists enthusiastic regarding the potential of the technology.<br />
<br />
The TransCatheter Aortic Valves Market Report offers an updated view of the market, growth trends and strategic landscape. The reports, which is targeted at senior executives in the medical device industry, profiles leading companies and their technologies and offers an event-impacted forecast to 2020.<br />
<br />
Companies mentioned in the report include Edwards Lifesciences, Medtronic, Boston Scientific, Bracco Group, Braile Biomedica, Direct Flow Medical, Hansen Medical, JenaValve, St. Jude Medical, Symetis and ValveXchange.<br />
<br />
<div style="text-align: center;">
<b>Published: October 2013 - #18 Pages - PDF by eMail</b></div>
<br />
<b>Table of Contents</b><br />
<br />
1. Global TransCatheter Aortic Valves Market<br />
<br />
2. Leading Companies & Their Devices<br />
<br />
2.1 Edwards Lifesciences<br />
<br />
2.2 Medtronic<br />
<br />
3. Leading Companies Market Shares<br />
<br />
4. Geographic Segmentation<br />
<br />
4.1 US TransCatheter Aortic Valves Market<br />
<br />
4.2 European TransCatheter Aortic Valves Market<br />
<br />
5. Other Companies In The Space<br />
<br />
5.1 Boston Scientific<br />
<br />
5.2 Bracco Group<br />
<br />
5.3 Braile Biomedica<br />
<br />
5.4 Direct Flow Medical<br />
<br />
5.5 Hansen Medical<br />
<br />
5.6 JenaValve<br />
<br />
5.7 St. Jude Medical<br />
<br />
5.8 Symetis<br />
<br />
5.9 ValveXchange<br />
<br />
6. TransCatheter Aortic Valve Technology<br />
<br />
6.1 Aortic Stenosis<br />
<br />
6.2 Balloon Aortic Valvuloplasty<br />
<br />
6.3 Surgical Aortic Valve Replacement<br />
<br />
6.4 TransCatheter Aortic Valve Repair<br />
<br />
6.5 Balloon-Expandable Vs Self-Expandable TransCatheter Aortic Valves<br />
<br />
6.6 Comparison Between TransFemoral & TransApical Approaches<br />
<br />
6.7 Hemodynamics of TransCatheter Valves<br />
<br />
6.8 Clinical Trials Update<br />
<br />
7. TransCatheter Aortic Valves Market Forecast<br />
<br />
<br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-47218494481106950452013-09-20T01:00:00.000-07:002013-10-13T07:18:42.573-07:00US Neurovascular Intervention Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=9" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi3vnAOFnwJ-RnOlSUaAIHRK4yDWC-6B5hFMJvxrem9hluP99_jH_BbyjKv9BsTPesJVsU6XlcpNE1jyxqPSWzPtgtHMopAShgPP_Cj8WeN-XknIcvIV9qGkSYSUaYaVbIFiiCnIAcYAYk/s1600/Order-Report.png" /></a>The US Neurovascular Intervention Market is expected to grow at an average annual growth rate of 6% over the next five years with thrombectomy devices, aneurysm stents and flow diversion devices offering above average growth.
<br />
<br />
<a name='more'></a>The addition of carotid stent systems to within the neurovascular boundaries coupled with continued consolidation in the space have transformed the strategic landscape of the market which is expected to continue to offer lucrative acquisition opportunities to leading participants and high valuations to innovative startups.<br />
<br />
The US Neurovascular Intervention Market Report segments the market into an endovascular aneurysm repair segment and a cerebral ischemia segment and analyzes leading device categories including embolic coils, intracranial aneurysm stents and flow diversion devices, liquid embolics, thrombectomy devices, intracranial ischemia stents as well as carotid stents and embolic protection devices.<br />
<br />
US Neurovascular Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this fast evolving field. It offers three linear forecast scenarios to 2020, and assesses product portfolios at leading companies in the space.<br />
<br />
The report examines recent acquisitions in the space together with their
implications on leading companies market shares and neurovascular
startup valuation and prospects. Leading companies profiled include Stryker, Covidien, Codman Neurovascular (Johnson & Johnson), Abbott Vascular and MicroVention (Terumo). Other companies mentioned include Boston Scientific, Cerus Endovascular, MindFrame, NeuroVasx, Nfocus Neuromedical, Penumbra, Reverse Medical, Valor Medical.<br />
<br />
<b>Published: September 2013 - Number of Pages: #18 Pages - PDF by eMail</b><br />
<br />
<b>Table of Contents</b><br />
<br />
1. Global Neurovascular Intervention Market<br />
2. US Neurovascular Intervention Market<br />
3. Leading Companies & Their Products<br />
4. Recent Acquisitions in the Neurovascular Space<br />
5. Leading Companies Market Shares<br />
6. US Endovascular Cerebral Aneurysm Repair Market<br />
6.1 US Neurovascular Embolic Coils Market<br />
6.2 US Aneurysm Stents & Flow Diversion Devices Market<br />
6.3 US Neurovascular Liquid Embolics Market<br />
7. US Ischemic Stroke Market<br />
7.1 US Cerebral Ischemia & Carotid Stents Market<br />
7.2 US Neurovascular Thrombectomy Device Market<br />
8. US Neurovascular Intervention Market Forecast<br />
<br />
<b>Tables & Figures</b><br />
<br />
1. Global Neurovascular Intervention Sales & Growth Rates (2008 – 2013)<br />
2. US Neurovascular Intervention Sales & Growth Rates (2008 – 2013)<br />
3. US Neurovascular Intervention – Device Category Segmentation (2013)<br />
4. US Neurovascular Intervention – Disease Area Segmentation (2013)<br />
5. US Endovascular Cerebral Aneurysm Repair (ECAR) 2008 – 2013<br />
6. US Endovascular Cerebral Aneurysm Repair – Device Segments (2013)<br />
7. US Cerebral Ischemia Market Revenue & Growth Rates (2008 – 2013)<br />
8. US Cerebral Ischemia Device Segmentats (2013)<br />
9. US Neurovascular Intervention Market Forecast (2014 – 2020) <br />
<br /></div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-834786849180257912013-09-18T06:00:00.000-07:002019-08-25T00:53:03.149-07:00Aortic Intervention Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=8" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgX8qeVSMFDvHCakNMpQp4MIg-TqwUqupt1v1BJVylFHGcGQ6gs57gdUs0I8fyWlvNEGZuOWVAHmvNKa-GpOcLDKfv8oWr8G3T7OviJ4DdMz3FK7uqdoXwY16Q7Ql8byBywQGGyl5_AbLw/s1600/Order-Report.png" /></a>Global aortic intervention market, which currently stands at $2 billion, has matured. Medtronic, Cook, Gore, Endologix and Terumo are currently the top five
leading aortic endograft companies and the size of their market share
reflects the order in which they have been mentioned. <br />
<br />
<a name='more'></a>Not all five companies are present in all anatomical segments of the market, or in all geographical locations for that matter. This represents an intriguing opportunity for consolidation through acquisitions during 2014 and interesting prospects for the many innovative start-ups that are starving for cash in this difficult space.<br />
<br />
With 71% share, abdominal aortic stent grafts account for the majority of the market. They experienced a resurgence during the previous three years due to the rollout of new lower profile devices designed to treat a wider universe of patients with tortuous, angulated aortas that were previously not eligible for EVAR.<br />
<br />
New generations of devices that further expand the universe of patients eligible for endovascular repair are expected to rollout in major markets with thought leaders predicting that before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.<br />
<br />
The Aortic Intervention Market Report attempts to answer some important questions regarding the fast evolving aortic intervention landscape. The report examines Leading companies technologies, product offerings, market shares and strategic positions. It uncovers areas with maturing trends as well as areas with high growth potential and provides an updated forecast to 2020.<br />
<br />
Leading companies profiled in the report include Medtronic, Cook Medical, Gore Medical, Endologix, Terumo and TriVascular. Other companies mentioned include Altura, Aptus Endosystems, Bolton Medical, Braile Biomedica, Braun, Cardiatis, Lifetech Scientific, Getinge, Johnson & Johnson, Jotec, Lombard Medical, Microport Medical and Nano Endoluminal.<br />
<br />
Aortic Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this two billion dollar fast growing market.<br />
<br />
<div style="text-align: center;">
<b>Published September 2013 - 40 Pages - PDF by eMail </b></div>
<br />
<b>Contents:</b><br />
<br />
1. Executive Summary<br />
<br />
2. Aneurysms<br />
<br />
2.1 Aortic Aneurysms<br />
2.2 Open Surgical Repair of Aortic Aneurysms<br />
2.3 Endovascular Repair of Aortic Aneurysms<br />
2.4 The Diaphragmatic Paradigm<br />
<br />
3. Global Aortic Intervention Market<br />
<br />
4. Top Five Aortic Intervention Companies<br />
<br />
4.1 Medtronic: Aortic Intervention Business<br />
4.2 Cook: Aortic Intervention Business<br />
4.3 Gore: Aortic Intervention Business<br />
4.4 Endologix: Aortic Intervention Business<br />
4.5 Terumo: Aortic Intervention Business<br />
<br />
5. Leading Companies Market Shares<br />
<br />
6. Other Companies In The Space<br />
<br />
7. Device Category Segmentation<br />
<br />
7.1 Abdominal Aortic Stent Grafts Market<br />
7.2 Thoracic Aortic Stent Grafts Market<br />
7.3 Fenestrated Aortic Stent Grafts Market<br />
<br />
8. Geographic Segmentation <br />
<br />
8.1 US Aortic Intervention Market<br />
8.2 European Aortic Intervention Market<br />
8.3 Japanese Aortic Intervention Market<br />
8.4 Chinese Aortic Intervention Market<br />
8.5 Latin America Aortic Intervention Market<br />
<br />
9. Aortic Intervention Market Forecast</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-58213413823231299362013-05-30T04:17:00.000-07:002013-10-13T07:18:55.752-07:00Neurovascular Intervention Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=2" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEMnMkmi0ogURyrhOWXVNHaGwyaub_vBMP9_ggTHt_82nERASe2JSpF_AJ1GuDDjSDng8K12SlAWH6wxa992ZqOkAJveGawVuVEk5paGRZBcWgbPbXVPF8CvfktlQeCMDIHyMpKqO2NUI/s1600/Order-Report.png" /></a>Global Neurovascular Intervention Market reached $1.5 billion in 2012. The market, which is still experiencing double digit growth is expected to surpass $2.5 billion by 2018.
<br />
<br />
<a name='more'></a>Stryker continued to consolidate its leading position in the neurovascular space by acquiring Concentric Medical in the fourth quarter of 2011 and Surpass Medical in fourth quarter of 2012; each for $135 million in cash.<br />
<br />
In January 2012 Covidien bought Reverse Medical’s neurovascular guide catheter business and Terumo acquired Onset Medical access sheath technology.<br />
<br />
The addition of carotid stent systems to within the neurovascular boundaries coupled with continued consolidation in the space have transformed the strategic landscape of the market which is expected to continue to offer lucrative acquisition opportunities for leading participants and high valuation for innovative startups.<br />
<br />
Neurovascular Intervention Market Report analyzes revenue and growth trends for the entire sector with special emphasis on embolic coils, intracranial stents, liquid embolics, carotid stents and thrombectomy devices.<br />
<br />
The report, which segments the market based on disease areas with special emphasis on cerebral aneurysm and both acute and chronic cerebral ischemia offers answers to many important questions including:<br />
<br />
How does the new neurovascular landscape look like? How have market shares been redistributed? What are current growth trends? How will the market evolve in the near future? What are the current critical success factors? and last, but not least, what are the current valuation levels for new technologies and innovative start-ups venturing into the space.<br />
<br />
Neurovascular Intervention Market Report is targeted at senior executives in the medical device industry who wish to get up-to-date with this multi-billion dollar fast growing market and offers an updated linear forecast to 2018.<br />
<br />
<b>Published: May 2013 - Number of Pages: #75 Pages - PDF by eMail</b><br />
<br />
<br />
<b>Table of Contents</b><br />
<br />
1. Executive Summary<br />
<br />
2. Global Neurovascular Intervention Market<br />
<br />
2.1 Market Revenue & Growth Trend<br />
2.2 Hemorrhagic Stroke Market<br />
2.3 Ischemic Stroke Market<br />
2.4 Top Five Neurovascular Intervention Companies<br />
2.4.1 Stryker<br />
2.4.2 Covidien<br />
2.4.3 Johnson & Johnson<br />
2.4.4 Abbott Vascular<br />
2.4.5 Terumo<br />
2.5 Leading Companies Market Shares<br />
2.6 Other Companies in the Space<br />
2.6.1 Balt Extrusion<br />
2.6.2 B. Braun<br />
2.6.3 Boston Scientific<br />
2.6.4 Cardiatis<br />
2.6.5 Cerus Endovascular<br />
2.6.6 Chestnut Medical<br />
2.6.7 CoAxia<br />
2.6.8 Codman Neurovascular<br />
2.6.9 Concentric Medical<br />
2.6.10 DePuy<br />
2.6.11 ev3<br />
2.6.12 Flexible Stenting Solutions<br />
2.6.13 Gore Medical<br />
2.6.14 ITGI Medical<br />
2.6.15 Merlin MD<br />
2.6.16 MicroVention<br />
2.6.17 Micrus Endovascular<br />
2.6.18 MindFrame<br />
2.6.19 NeuroVasx<br />
2.6.20 Nfocus Neuromedical<br />
2.6.21 Penumbra<br />
2.6.22 Phenox GmbH<br />
2.6.23 Reverse Medical<br />
2.6.24 Sequent Medical<br />
2.6.25 Surpass Medical<br />
2.6.26 Valor Medical<br />
<br />
3. Geographic Segmentation<br />
<br />
3.1 US Neurovascular Intervention Market<br />
3.2 European Neurovascular Intervention Market<br />
3.3 Japanese Neurovascular Intervention Market<br />
<br />
4. Disease Area Segmentation<br />
<br />
4.1 Endovascular Cerebral Aneurysm Repair Market<br />
<br />
4.1.1 Cerebral Aneurysm<br />
4.1.2 Natural History and Demographics<br />
4.1.3 Surgical Repair of Cerebral Aneurysms (Clipping)<br />
4.1.5 Endovascular Repair of Cerebral Aneurysms(Coiling)<br />
4.1.6 Balloon Assisted Coiling<br />
4.1.7 Stent Assisted Coiling<br />
4.1.8 Polymer Embolics<br />
4.1.9 Hemodynamic Repair of Cerebral Aneurysms<br />
<br />
4.2 Acute Ischemic Stroke (AIS) Market<br />
<br />
4.2.1 Medical Management of AIS<br />
4.2.2 Thrombectomy and Clot Retrieval<br />
<br />
4.3 Intracranial Atherosclerotic Disease (ICAD) Market<br />
<br />
4.3.1 Medical Management of ICAD<br />
4.3.2 Surgical Revascularization<br />
4.3.4 Intracranial Angioplasty & Stenting<br />
<br />
5. Device Category Segmentation<br />
<br />
5.1 Neurovascular Embolic Coils Market<br />
<br />
5.1.1 Market Overview & Growth Trend<br />
5.1.2 Trend in Use in Ruptured & Un-ruptured Aneurysms<br />
5.1.3 Leading Companies & Their Products<br />
5.1.4 Bare Metal, Coated and Bio-Active Coils<br />
5.1.5 Geographic Segmentation<br />
5.1.6 Leading Companies Market Shares<br />
<br />
5.2 Neurovascular Liquid Embolics Market<br />
<br />
5.2.1 Market Overview & Growth Trend<br />
5.2.2 Arterio Venous Malformations (AVMs)<br />
5.2.3 Leading Companies & Their Products<br />
5.2.4 Leading Companies Market Shares<br />
<br />
5.3 Intracranial Stents & Flow Diverting Devices Market<br />
<br />
5.3.1 Market Overview & Growth Trend<br />
5.3.2 Cerebral Aneurysm Stents Market<br />
5.3.3 Assisted Coil Insertion Stents Market<br />
5.3.4 Flow Diverting Devices Market<br />
5.3.5 Cerebral Ischemia Stents Market<br />
5.3.6 Geographic Segmentation<br />
5.3.7 Leading Companies Market Shares<br />
<br />
5.4 Neurovascular Thrombectomy Device Market<br />
<br />
5.4.1 Market Overview & Growth Trend<br />
5.4.2 Leading Companies & Their Products<br />
5.4.3 Geographic Segmentation<br />
5.4.4 Leading Companies Market Shares<br />
<br />
5.5 Carotid Stents & Embolic Protection Devices Market<br />
<br />
5.5.1 Market Overview & Growth Trend<br />
5.5.2 Leading Companies & Their Products<br />
5.5.3 Geographic Segmentation<br />
5.5.4 Leading Companies Market Shares<br />
<br />
6. Valuation in the Neurovascular Space<br />
<br />
6.1 ev3 Chestnut Medical Deal<br />
6.2 Covidien ev3 Deal<br />
6.3 DePuy Micrus Endovascular Deal<br />
6.4 Stryker Boston Scientific Deal<br />
6.5 Stryker Concentric Medical Deal<br />
6.6 Stryker Surpass Medical Deal<br />
<br />
7. Future Outlook<br />
<br />
7.1 Market Drivers<br />
7.2 Technological Trends<br />
7.3 Market Forecast<br />
<br />
<b>Tables & Figures</b><br />
<br />
1. Neurovascular Intervention Market – Revenue & Growth Rates (2007 – 2012)<br />
2. Neurovascular Intervention Market – Geographic Segmentation (2012)<br />
3. Neurovascular Intervention Market – Disease Area Segmentation (2012)<br />
4. Neurovascular Intervention Market – Device Category Segmentation (2012)<br />
5. Neurovascular Intervention Market – Leading Companies Market Shares (2012)<br />
6. Covidien Neurovascular Business Unit Revenue (2007 – 2012)<br />
7. Stryker Neurovascular Business Unit Revenue (2007 – 2012)<br />
8. Terumo Neurovascular Business Unit Revenue (2007 – 2012)<br />
9. Neurovascular Coils Market – Revenue & Growth Rates (2007 – 2012)<br />
10. Neurovascular Coils Market – Geographic Segmentation (2012)<br />
11. Neurovascular Coils Market – Disease Area Segmentation (2012)<br />
12. Neurovascular Coils Market – Device Category Segmentation (2012)<br />
13. Neurovascular Coils Market – Leading Companies Market Shares (2012)<br />
14. Intracranial Stents Market – Revenue & Growth Rates (2007 – 2012)<br />
15. Intracranial Stents Market – Geographic Segmentation (2012)<br />
16. Intracranial Stents Market – Device Category Segmentation (2012)<br />
17. Intracranial Stents Market – Leading Companies Market Shares (2012)<br />
18. Liquid Embolics Systems Market – Revenue & Growth Rates (2007 – 2012)<br />
19. Liquid Embolics Systems Market – Leading Companies Market Shares (2012)<br />
20. Neurovascular Thrombectomy Market – Revenue & Growth Rates (2007 – 2012)<br />
21. Neurovascular Thrombectomy Market – Geographic Segmentation (2012)<br />
22. Neurovascular Thrombectomy Market – Leading Companies Market Shares (2012)<br />
23. Carotid Stents Market – Revenue & Growth Rates (2007 – 2012)<br />
24. Carotid Stents Market – Geographic Segmentation (2012)<br />
25. Carotid Stents Market – Leading Companies Market Shares (2012)<br />
26. US Neurovascular Intervention Market – Revenue & Growth Rates (2007 – 2012)<br />
27. US Neurovascular Intervention Market – Device Category Segmentation (2012)<br />
28. US Neurovascular Intervention Market – Companies Market Shares (2012)<br />
29. EU Neurovascular Intervention Revenue & Growth Rates (2007 – 2012)<br />
30. EU Neurovascular Intervention Market – Device Category Segmentation (2012)<br />
31. EU Neurovascular Intervention Market – Companies Market Shares (2012)<br />
32. Japan Neurovascular Intervention Revenue & Growth Rates (2007 – 2012)<br />
33. Japan Neurovascular Intervention – Device Category Segmentation (2012)<br />
34. Japan Neurovascular Intervention Market – Companies Market Shares (2012)<br />
35. Neurovascular Intervention Market Forecast (2013 – 2018)</div>
Unknownnoreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-16390336053459533812012-11-16T01:44:00.000-08:002019-09-08T09:15:21.833-07:00Endothelial Homeostasis Hypothesis<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://secure.2checkout.com/checkout/buy?merchant=1912926&tpl=default&prod=102&qty=1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt=" Endothelial Homeostasis Hypothesis" border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgvWHbbSSHRIfLqo_N_glIbsN8dr6yWyrThk8AguP-NdtXlBB3_3IAIAiLYQQmLjEScTDNmKjq9PKeyXqegwHqKdRkE6YHzJfxgG17-7Z9AzaFaWLqfEqQmh4vCApvixM_MRHfTokbLTk8/s1600/Order-Report.png" /></a></div>
Recent research indicates that aneurysms are the symptomatic manifestation of an age-related degenerative process. Recent research also indicates that endothelial cells actively sense and respond to focal disturbances in blood flow and to the resulting rise in wall shear stress.<br />
<br />
<a name='more'></a>The Endothelial Homeostasis Hypothesis offers a new way of looking at the process of aneurysm initiation, progression and rupture and promises to guide future research into the endovascular aneurysm repair field.<br />
<br />
This report, which is targeted at senior executives in both the medtech and biotech industries, summarizes the Endothelial Homeostasis Hypothesis and highlights the potential for new therapies in the field.<br />
<br />
<div style="text-align: center;">
<b> Published November 2014 - 10 Pages - PDF by eMail</b></div>
</div>
Ronhttp://www.blogger.com/profile/03808598439570553667noreply@blogger.comtag:blogger.com,1999:blog-6276472296806617923.post-36887039633453315482012-07-18T04:29:00.000-07:002013-10-13T07:19:25.802-07:00Renal Denervation Market<div dir="ltr" style="text-align: left;" trbidi="on">
<a href="https://www.2checkout.com/checkout/purchase?sid=1912926&quantity=1&product_id=3" rel="nofollow" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjEMnMkmi0ogURyrhOWXVNHaGwyaub_vBMP9_ggTHt_82nERASe2JSpF_AJ1GuDDjSDng8K12SlAWH6wxa992ZqOkAJveGawVuVEk5paGRZBcWgbPbXVPF8CvfktlQeCMDIHyMpKqO2NUI/s1600/Order-Report.png" /></a>Renal artery denervation, a new device-based therapeutic paradigm for managing treatment resistant hypertension, has come of age and is attracting an unprecedented gold rush from serial medical device entrepreneurs.
<br />
<br />
<a name='more'></a>Medtronic’s acquisition of Ardian for $800 million plus $500 million more in milestone payments in January 2011 signaled the dawning of a new era of catheter-based renal denervation systems.<br />
<br />
Results of the Symplicity HTN-1 and Symplicity HTN-2 trials have generated considerable interest among physicians, patients, medical device entrepreneurs, and the investment community.<br />
<br />
The market, although still in the inception phase, has already attracted heavy hitters with Covidien paying $230 Million for Maya Medical’ OneShot renal denervation system, St. Jude launching its EnligHTN renal denervation system in Europe in May 2012 and Boston Scientific diverting its R&D resources for a first-in-man with a new device before the end of 2012.<br />
<br />
Renal denervation is a catheter-based therapy that uses either radiofrequency or ultrasound energy to disrupt the renal arteries sympathetic nerves whose hyperactivity may lead to treatment-resistant hypertension.<br />
<br />
Renal denervation systems are perhaps the hottest medical device innovation space this year as they offer a complementary approach to the management of resistant hypertension that was not available before.<br />
<br />
Renal Denervation Market report attempts to answer some important questions regarding the fast evolving market by examining Leading companies technologies, product offerings, market shares. The report offers a credible forecast to 2016.<br />
<br />
Renal Denervation Market report is targeted at senior executives in the medical device space, innovators, serial medtech entrepreneurs and ventures capitalists who wish to get a handle on this potentially $3 billion fast growing opportunity.<br />
<br />
<b>Published: June 2012 - #26 Pages - PDF by eMail</b><br />
<br />
<b>Table of Contents</b><br />
<br />
1. Executive Summary<br />
<br />
2. State of the Science<br />
<br />
2.1 Treatment Resistant Hypertension<br />
2.2 Renal Sympathetic Nervous System<br />
2.3 Role of Kidney Sympathetic Nerves in Hypertension<br />
2.4 Selective Renal Artery Denervation<br />
2.5 Clinical Trials Update<br />
<br />
3. Renal Artery Denervation Technology<br />
<br />
3.1 Renal Artery Denervation Procedure<br />
3.2 Radio Frequency Renal Artery Denervation Systems<br />
3.3 Ultrasound Renal Artery Denervation Systems<br />
3.4 Microinfusion Renal Denervation Systems<br />
<br />
4. Renal Artery Denervation Market<br />
<br />
4.1 Current Market Situation<br />
4.2 Medtronic Symplicity Radio Frequency Renal Denervation System<br />
4.3 St. Jude EnligHTN Radio Frequency Renal Denervation System<br />
4.4 ReCor Paradise Ultrasound Renal Denervation System<br />
4.5 Vessix Vascular V2 Radio Frequency Renal Denervation System<br />
<br />
5. In-Development Renal Artery Denervation Devices<br />
<br />
5.1 Current Renal Denervation R&D Landscape<br />
5.2 CardioSonic TIVUS Ultrasound Renal Denervation System<br />
5.3 Kona Externally Applied Ultrasound Renal Denervation System<br />
5.4 Covedien OneShot Radio Frequency Renal Denervation System<br />
5.5 Mercator Bullfrog Microinfusion Renal Denervation System<br />
5.6 Other Companies Contemplating an Entry into the Renal Denervation Space<br />
<br />
6. Renal Denervation Market Forecast<br />
<br />
6.1 Market Potential<br />
6.2 Market Evolution Scenarios<br />
6.3 Market Forecast<br />
<br />
List of Tables & Figures<br />
<br />
1. Renal Denervation Market Forecast (2011 – 2016)<br />
2. Hypertension & Cardiovascular Mortality Risk<br />
3. Efferent & Afferent Renal Sympathetics<br />
4. Chronic Effects of Increased Sympathetic Activity<br />
5. Renal Artery Sympathetic Enervation<br />
6. Targeting Renal Artery Nerves<br />
7. Radio Frequency Renal Denervation Systems<br />
8. Ultrasound Renal Denervation Systems<br />
9. Microinfusion Renal Denervation Systems<br />
10. Commercially Available Renal Denervation Systems<br />
11. Medtronic Symplicity Renal Denervation System<br />
12. St. Jude EnligHTN Renal Denervation System<br />
<br />
13. ReCor Paradise Renal Denervation System<br />
<br />
14. Vessix Vascular V2 Renal Denervation System<br />
<br />
15. Renal Artery Denervation Market Potential<br />
<br />
16. Renal Artery Denervation Market Evolution Scenarios (2011 – 2016)<br />
<br />
17. Renal Denervation Market Forecast (2011 – 2016)</div>
Unknownnoreply@blogger.com